This inventor holds 19 USPTO granted patents and 11 published patent applications and 3 EPO patents. Top assignees: Cyrano Therapeutics, Inc., The United States of America as Represented by the Department of Health, Other. Active years: 1976-2026.
Company Filing History:
9 out of 9 
2 out of 1,217 
8 out of 834,350 Years Active: 1976-2026
Title: **Robert I. Henkin: Innovator in Taste and Smell Disorders**
Introduction
Robert I. Henkin, based in Bethesda, MD, is a distinguished inventor with a notable portfolio of 18 patents. His innovative contributions primarily focus on medical treatments and diagnosis related to taste and smell disorders, marking significant strides in the fields of pharmacology and sensory research.
Latest Patents
Among his latest patents, Henkin has developed methods and compositions for treating diseases associated with low levels of cyclic nucleotides through phosphodiesterase inhibitors. These formulations are specifically designed for intranasal and pulmonary administration, showcasing his commitment to advancing therapeutic techniques. Additionally, he has disclosed methods for diagnosing and treating conditions related to the loss or distortion of taste and smell. This includes various sensory disorders such as hyposmia, dysosmia, anosmia, phantosmia, hypogeusia, dysgeusia, phantogeusia, and ageusia. His work promises to enhance the quality of life for individuals affected by these conditions.
Career Highlights
Throughout his career, Henkin has demonstrated a profound dedication to research and development in sensory ailments. His extensive list of patents reflects his innovative approach to overcoming obstacles linked to taste and smell, as well as his involvement in advancing pharmacological sciences. His contributions have significantly influenced the understanding and treatment of these sensory disorders.
Collaborations
Robert I. Henkin has collaborated with professionals in the field, notably with Eugene L. Giroux, to further the development of his innovative treatments. As a member of Cyrano Therapeutics, Inc., he has worked on various projects aimed at enhancing diagnostic methodologies and therapeutic options for sensory dysfunctions.
Conclusion
With a prolific career characterized by 18 patents and numerous advancements in the treatment of taste and smell disorders, Robert I. Henkin exemplifies the impact that dedicated inventors can have on healthcare. His work not only expands the possibilities for treatment but also offers hope to many individuals suffering from sensory conditions. The ongoing exploration of his patented methods and compositions remains a vital part of medical research and innovation.